To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
The FDA says state-licensed compounding pharmacies must immediately stop making compound versions of GLP-1 drugs. Larger, national licensed facilities making compound versions of Zepbound have until ...